Chronic lung allograft dysfunction: Definition and update of restrictive allograft syndrome-A consensus report from the Pulmonary Council of the ISHLT

Affiliations

• ¹ Lung Transplant Unit, St. Vincent's Hospital, Sydney, New South Wales, Australia.
• ² University Hospital Gasthuisberg, Leuven, Belgium. Electronic address: geert.verleden@uzleuven.be.
• ³ Division of Pulmonary, Allergy and Critical Care Medicine, Duke University, Durham, North Carolina, USA.
• ⁴ University Hospital Zurich, Zurich, Switzerland.
• ⁵ Department of Cardiothoracic and Vascular Sciences, University of Padova Medical School, Padova, Italy.
• ⁶ Department of Respiratory Medicine, Hannover Medical School, Member of the German Center for Lung Research, Hannover, Germany.
• ⁷ Division of Pulmonary & Critical Care, Washington University in St. Louis, St. Louis, Missouri, USA.
• ⁸ Pulmonary Disease and Critical Care Medicine, University of Texas Health Science Center San Antonio, San Antonio, Texas, USA.
• ⁹ Department of Respiratory Diseases Policlinico San Matteo Foundation & University of Pavia, Pavia, Italy.
• ¹⁰ Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
• ¹¹ Department of Thoracic Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
• ¹² Toronto Lung Transplant Program, University Health Network, University of Toronto, Toronto, Ontario, Canada.
• ¹³ Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.
• ¹⁴ University Hospital Gasthuisberg, Leuven, Belgium.
• ¹⁵ Department of Pathology, University Medical Center, Rotterdam, The Netherlands.
• ¹⁶ Lung Transplant Service, The Alfred Hospital, Melbourne, Victoria, Australia.